May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Histone Deacetylase Inhibitors Suppress Matrix Metalloproteinase Secretion from Human Optic Nerve Astrocytes
Author Affiliations & Notes
  • C.E. Crosson
    Medical University of South Carolina, Charleston, SC
    Ophthalmology,
  • M.A. Haracznak
    Medical University of South Carolina, Charleston, SC
    Ophthalmology,
  • M.D. Covington
    Medical University of South Carolina, Charleston, SC
    Medicine,
  • L. Xu
    Medical University of South Carolina, Charleston, SC
    Medicine,
  • D.R. Menick
    Medical University of South Carolina, Charleston, SC
    Medicine,
  • Footnotes
    Commercial Relationships  C.E. Crosson, None; M.A. Haracznak, None; M.D. Covington, None; L. Xu, None; D.R. Menick, None.
  • Footnotes
    Support  EY–09741 and EY–14793
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2618. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.E. Crosson, M.A. Haracznak, M.D. Covington, L. Xu, D.R. Menick; Histone Deacetylase Inhibitors Suppress Matrix Metalloproteinase Secretion from Human Optic Nerve Astrocytes . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2618.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Previous studies have provided evidence that the secretion and activation of matrix metalloproteinases (MMPs) from astocytes contributes to retinal damage induced by inflammation, and ischemic injury. The purpose of these studies was to investigate the impact of histone deacetylase (HDAC) inhibitors on matrix metalloproteinase expression induced by the inflammatory cytokine TNFα.

Methods: : To stimulate MMP secretion from cultured primary human astrocytes cell were incubated with TNFα (10 ng/ml) for 24 hours. To investigate the role of HDACs cells were pretreated with the nonselective HDAC inhibitor trichostatin A (TSA; 10 –100 nM) for 1 hour prior to the addition of TNFα. The secretion of MMP–1 and –3 and histone–4 acetylation were determined by Western blot analysis. The expression of individual HDACs was determined by RT–PCR.

Results: : The addition of TNFα for 24 hours significantly increased the secretion of MMP–1 and MMP–3, over control levels, by 270% and 101%, respectively. Pretreatment with TSA (100 nM) blocked the TNFα–induced secretion MMP1 and MMP3. This inhibition by TSA was dose–related, with IC50s ranging from 10 to 22 nM. Treatment of astorcytes with TSA (100 nM) significantly increased histone–4 acetylation. RT–PCR analysis demonstrated that the principal HDACs expressed in human optic nerve astrocytes were HDAC2, 3, 6, and 8.

Conclusions: : These studies demonstrate that the HDAC inhibitor TSA can block the induction and secretion of matrix metalloproteinases induced by the proinflammatory cytokine TNFα.. Hence, histone deacetylation may be an early required step in the expression and secretion of matrix metalloproteinase from optic nerve astrocytes. The use of HDAC inhibitors may provide a novel approach for the prevention and treatment of optic neuropathies.

Keywords: astrocytes: optic nerve head • pharmacology • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×